@prefix : <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opv: <http://inab.certh.gr/OpenPVSignal> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix openpvsignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl> .
@base <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl> .

<http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl> rdf:type owl:Ontology ;
                                                                                        owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ;
                                                                                        rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/272295/"^^xsd:anyURI ;
                                                                                        rdfs:label "Ivermectin and serious neurological events"^^rdfs:Literal ;
                                                                                        owl:versionInfo "draft-v0.95-20210319"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


###  http://purl.org/mp/supportedByData
mp:supportedByData rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#refers_to_rechallenge_outcome
:refers_to_rechallenge_outcome rdf:type owl:DatatypeProperty .


#################################################################
#    Classes
#################################################################

###  http://www.w3.org/ns/prov#Organization
<http://www.w3.org/ns/prov#Organization> rdf:type owl:Class .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Acarodermatitis
:Acarodermatitis rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B86" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10063409 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Acarodermatitis" ;
                 rdfs:label "acarodermatitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo1
:AdditionalInfo1 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered in 24 hours
Positive dechallenge""" ;
                 rdfs:label "Additional info 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo10
:AdditionalInfo10 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered" ;
                  rdfs:label "Additional info 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo11
:AdditionalInfo11 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered; Similar
symptoms reports twice in
the past after ivermectin""" ;
                  rdfs:label "Additional info 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo12
:AdditionalInfo12 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Not recovered" ;
                  rdfs:label "Additional info 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo13
:AdditionalInfo13 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered
Positive dechallenge with all
3 drugs. Patient had started
darunavir 12 months prior
and ritonavir 8 days prior.""" ;
                  rdfs:label "Additional info 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo14
:AdditionalInfo14 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Drug withdrawn, no effect
observed
MRI abnormal 2 weeks after
dosing""" ;
                  rdfs:label "Additional info 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo15
:AdditionalInfo15 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  mp:references :Ref.7 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Drug withdrawn, fatal outcome. 
Therapy initiated for Strongyloides stercoralis infection in patient
on prednisone for giant cell arteritis. 
Patient was s/p aortic valve replacement.
Ivermectin levels measured in brain tissue at autopsy (30 ng/g). 
None of the most common polymorphisms in mdrn/a1 present.
A 64-year-old male with a past medical history of giant cell arteritis, treated with prednisone developed sepsis, complicated by multisystem organ failure, after an aortic valve replacement. Sputum culture revealed S. stercoralis. A diagnosis of S. stercoralis hyperinfection syndrome was made; he was initiated on ivermectin 12 mg every 48 hours. He received three oral doses followed by two subcutaneous doses. In spite of clinical and microbiological improvement, the patient remained in a vegetative state and died on day 25. Autopsy revealed an elevated level of ivermectin in the brain tissue, 14 days after the last dose.‚Äù.7""" ;
                  rdfs:label "Additional info 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo16
:AdditionalInfo16 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Positive dechallenge" ;
                  rdfs:label "Additional info 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo17
:AdditionalInfo17 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Drug withdrawn, no effect
observed""" ;
                  rdfs:label "Additional info 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo19
:AdditionalInfo19 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Hospitalised, recovered" ;
                  rdfs:label "Additional info 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo2
:AdditionalInfo2 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Positive dechallenge" ;
                 rdfs:label "Additional info 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo20
:AdditionalInfo20 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered with sequelae" ;
                  rdfs:label "Additional info 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo21
:AdditionalInfo21 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Hospitalised" ;
                  rdfs:label "Additional info 21" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo23
:AdditionalInfo23 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Drug withdrawn, no effect
observed""" ;
                  rdfs:label "Additional info 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo24
:AdditionalInfo24 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered" ;
                  rdfs:label "Additional info 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo25
:AdditionalInfo25 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered" ;
                  rdfs:label "Additional info 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo26
:AdditionalInfo26 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered" ;
                  rdfs:label "Additional info 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo27
:AdditionalInfo27 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered
Hospitalised 4 hours, gastric
lavage""" ;
                  rdfs:label "Additional info 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo28
:AdditionalInfo28 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Recovered" ;
                  rdfs:label "Additional info 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo29
:AdditionalInfo29 rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered
Positive dechalleng""" ;
                  rdfs:label "Additional info 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo3
:AdditionalInfo3 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Not recovered" ;
                 rdfs:label "Additional info 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo4
:AdditionalInfo4 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Positive rechallenge" ;
                 rdfs:label "Additional info 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo7
:AdditionalInfo7 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Died, 5 days after last dose
from the events of
depressed level of
consciousness and
asphyxia. Digoxin
initiated 1 day prior to death.""" ;
                 rdfs:label "Additional info 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo8
:AdditionalInfo8 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered
Positive dechallenge
LP, EEG and MRI all
performed""" ;
                 rdfs:label "Additional info 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#AdditionalInfo9
:AdditionalInfo9 rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Recovered
Positive dechallenge""" ;
                 rdfs:label "Additional info 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Avermectins
:Avermectins rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Avermectins_mechanism ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "QP54AA" ;
             rdfs:label "Avermectins" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Avermectins_mechanism
:Avermectins_mechanism rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "avermectins, which are highly active broad-spectrum, anti-parasitic agents." ;
                       rdfs:label "Avermectins mechanism" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Clinical_trial_information_for_ivermectin
:Clinical_trial_information_for_ivermectin rdf:type owl:NamedIndividual ,
                                                    <http://purl.obolibrary.org/obo/OAE_0001197> ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Clinical_trial_information> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Strongyloidiasis ,
                                                                                                                       :onchocerciasis ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :dizziness ,
                                                                                                                    :headache ,
                                                                                                                    :somnolence ,
                                                                                                                    :tremor ,
                                                                                                                    :vertigo ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                                           mp:references :Ref.1 ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The neurological events of dizziness (2.8%), somnolence (0.9%), vertigo (0.9%), and tremor (0.9%) were observed in human clinical trials for the treatment of strongyloidiasis, while drug-related headache (0.2%) was observed in trials for onchocerciasis; these events are included in the product label." ;
                                           rdfs:label "Clinical trial information for ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Conjunctival_hemorrhage
:Conjunctival_hemorrhage rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "H11.3" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010720 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Conjunctival hemorrhage" ;
                         rdfs:label "conjunctival hemorrhage" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Difficulty_in_standing
:Difficulty_in_standing rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10050218 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Difficulty in standing" ;
                        rdfs:label "difficulty in standing" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Difficulty_in_walking
:Difficulty_in_walking rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012794 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Difficulty in walking" ;
                       rdfs:label "difficulty in walking" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Discussion_and_Conclusion
:Discussion_and_Conclusion rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Conclusion> ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Discussion> ;
                           mp:references :Ref.10 ,
                                         :Ref.11 ,
                                         :Ref.3 ,
                                         :Ref.8 ,
                                         :Ref.9 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "This case series describes SNAEs with the use of ivermectin beyond its indication for O. volvulus. Ivermectin acts by binding to glutamate-gated chloride ion channels which occur in invertebrate nerve and muscle cells; an increase in the permeability of the cell membrane results in paralysis and death of the parasite. It can also bind to mammalian GABA receptors and GABA-gated ion channels; however, neurotoxicity is prevented by the action of the P-glycoprotein drug pump (mdr-1) which limits penetration of the blood- brain barrier within the allowable dosage ranges for humans.3 It is well established in the veterinary world that certain breeds of dogs, such as collies, are sensitive to the neurotoxic effects of ivermectin; a loss of function in the mdr-1 gene in these breeds allows for an accumulation of ivermectin within the brain.8 Symptoms of neurotoxicity include lethargy, drooling, tremors/seizures, inability to stand, disorientation, coma. Our data suggest that individuals may experience SNAEs outside the contexts of overdose and L. loa co-infection. While a number of AEs experienced by subjects in this case series are included in the product label (dizziness, headache, tremor), there were many other events which are similar to those described as neurotoxic effects as found in overdose or in susceptible dogs: coma, loss of consciousness/depressed level of consciousness, abasia and coma. A number of cases included in the case series may be related to concomitantly administered drugs. Drugs that are substrates of CYP3A4 enzymes are often also substrates for Pglycoprotein transport, and thus there may be a risk of increased absorption past the bloodbrain barrier with concomitant adminstration.9 Several cases presented here reported concomitant use of such drugs, such as statins, HIV protease inhibitors, calcium channel blockers, and benzodiazepines. Current labelling for ivermectin contains no warning for co-administration with CYP3A4 substrates. Another possible explanation is that some humans experiencing an SNAE after ivermectin therapy may also have mutations in the mdr-1 gene, allowing for penetration of ivermectin into the central nervous system. More than 50 naturally occurring single nucleotide polymorphisms (SNP) have been identified in the mdr-1 gene; the majority of these SNP are silent, and there is no current evidence of a mutation that results in loss of function. However, various combinations of these SNP, comprising different P-glycoprotein haplotypes, have been found to exhibit reduced mdr-1 expression.10 Bourguinat et al performed a study in which they analysed mdr-1 genotypes in 13 subjects from Cameroon: four who experienced a serious adverse event and nine who did not. Haplotypes associated with altered drug disposition were present as homozygotes in two of the serious AE patients and in none of the control patients.11 One of the cases in our series was investigated for the most common polymorphisms associated with decreased mdr-1 expression and found that none were present; however, further details were not provided.8 In conclusion, there is evidence that SNAEs can occur with ivermectin beyond the treatment of O. volvulus complicated by concomitant L. loa infection. Potential explanations include concomitantly administered drugs which inhibit CYP3A4 and polymorphisms in the mdr-1 gene." ;
                           rdfs:label "Discussion and Conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage1
:Dosage1 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """15 mg, one
dose""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 15 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "15 mg" ;
         rdfs:label "Dosage 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage10
:Dosage10 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, 2
doses
separated by
one week""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
          rdfs:label "Dosage 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage11
:Dosage11 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """18 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 18 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "18 mg" ;
          rdfs:label "Dosage 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage12
:Dosage12 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """18 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 18 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "18 mg" ;
          rdfs:label "Dosage 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage13
:Dosage13 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12mg,one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage14
:Dosage14 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """3 mg, one
dose on two
days""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 3 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "3 mg" ;
          rdfs:label "Dosage 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage15
:Dosage15 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg oral,
then
subcutaneous""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage16
:Dosage16 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
          rdfs:label "Dosage 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage17
:Dosage17 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """21 mg, one
dose on 2
days""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 21 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "21 mg" ;
          rdfs:label "Dosage 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage19
:Dosage19 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """3 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 3 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "3 mg" ;
          rdfs:label "Dosage 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage2
:Dosage2 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, 1 per
1 day""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
         rdfs:label "Dosage 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage20
:Dosage20 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 6 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "6 mg" ;
          rdfs:label "Dosage 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage21
:Dosage21 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg " ;
          rdfs:label "Dosage 21" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage22
:Dosage22 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """18 mg, one
dose on 2
days""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 18 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "18 mg" ;
          rdfs:label "Dosage 22" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage23
:Dosage23 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage24
:Dosage24 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage25
:Dosage25 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
          rdfs:label "Dosage 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage26
:Dosage26 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
          rdfs:label "Dosage 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage27
:Dosage27 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage28
:Dosage28 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, one
dose""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
          rdfs:label "Dosage 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage29
:Dosage29 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, 2 doses
separated by
one week""" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
          rdfs:label "Dosage 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage3
:Dosage3 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, 1 per
1 day""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
         rdfs:label "Dosage 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage4
:Dosage4 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """18 mg, 2
doses
separated by
one week""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 18 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "18 mg" ;
         rdfs:label "Dosage 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage5
:Dosage5 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """2 tablets, 2
doses
separated by
one week""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "tablet" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "2 tablet" ;
         rdfs:label "Dosage 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage6
:Dosage6 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """24 mg, one
dose""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 24 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "24 mg" ;
         rdfs:label "Dosage 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage7
:Dosage7 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """12 mg, 2
doses
separated by
one week""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 12 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "12 mg" ;
         rdfs:label "Dosage 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage8
:Dosage8 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """9 mg, one
dose""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "9 mg" ;
         rdfs:label "Dosage 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dosage9
:Dosage9 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """1 DF, 1 per
1 day""" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
         rdfs:label "Dosage 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Dr_Rebecca_E_Chandler
:Dr_Rebecca_E_Chandler rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Author> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_affiliation> "Upsalla Monitoring Centre" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_first_name> "Rebecca" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_last_name> "Chandler" ;
                       rdfs:label "Dr Rebecca E Chandler" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Fecal_incontinence
:Fecal_incontinence rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R15" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016296 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Fecal incontinence" ;
                    rdfs:label "fecal incontinence" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#FilariasisDueToWuchereriaBancrofti
:FilariasisDueToWuchereriaBancrofti rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B74.0" ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10004085 ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Bancroftian filariasis" ;
                                    rdfs:label "bancroftian filariasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Infection_parasitic
:Infection_parasitic rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B89" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10021857 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Infection parasitic" ;
                     rdfs:label "infection parasitic" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ivermectin_and_serious_neurological_events
:Ivermectin_and_serious_neurological_events rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Pharmacovigilance_Signal_Report> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_author> :Dr_Rebecca_E_Chandler ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_signal> :pvSignal ;
                                            mp:publishedBy :Uppsala_Monitoring_Centre ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_creation_date> "1/1/2018"^^xsd:date ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_overall_conclusion> "causal association" ;
                                            rdfs:label "Ivermectin and serious neurological events" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ivermectin_mechanism
:Ivermectin_mechanism rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                      mp:references :Ref.3 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ivermectin acts by binding to glutamate-gated chloride ion channels which occur in invertebrate nerve and muscle cells; an increase in the permeability of the cell membrane results in paralysis and death of the parasite. It can also bind to mammalian GABA receptors and GABA-gated ion channels; however, neurotoxicity is prevented by the action of the P-glycoprotein drug pump (mdr-1) which limits penetration of the blood- brain barrier within the allowable dosage ranges for humans" ;
                      rdfs:label "Ivermectin mechanism" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Lethargy
:Lethargy rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R53.83" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10024264 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Lethargy" ;
          rdfs:label "lethargy" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Literature_and_Labelling
:Literature_and_Labelling rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Literature_information> ;
                          mp:references :Ref.1 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The neurological events of dizziness (2.8%), somnolence (0.9%), vertigo (0.9%), and tremor (0.9%) were observed in human clinical trials for the treatment of strongyloidiasis, while drug-related headache (0.2%) was observed in trials for onchocerciasis; these events are included in the product label. Also included in the labelling is a warning for overdose which can manifest with headache, dizziness, asthenia, seizure, ataxia, and paresthesia.1 The label for ivermectin also provides the following warning: ‚ÄúRarely, patients with onchocerciasis who are also heavily infected with Loa loa may develop a serious or even fatal encephalopathy either spontaneously or following treatment with an effective microfilaricide. In these patients, the following adverse experiences have also been reported: pain (including neck and back pain), red eye, conjunctival hemorrhage, dyspnea, urinary and/or fecal incontinence, difficulty in standing/ walking, mental status changes, confusion, lethargy, stupor, seizures, or coma. This syndrome has been seen very rarely following the use of ivermectin. In individuals who warrant treatment with ivermectin for any reason and have had significant exposure to Loa loa-endemic areas of West or Central Africa, pre-treatment assessment for loiasis and careful post- treatment follow-up should be implemented.‚Äù.1" ;
                          rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Mental_status_changes
:Mental_status_changes rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10048294 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Mental status changes" ;
                       rdfs:label "mental status changes" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Myiasis
:Myiasis rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B87" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028586 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Myiasis" ;
         rdfs:label "myiasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Neck_pain
:Neck_pain rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M54.2" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028836 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Neck pain" ;
           rdfs:label "neck pain" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Nematodiasis
:Nematodiasis rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B82.0" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10062701 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nematodiasis" ;
              rdfs:label "nematodiasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Neurological_disorders
:Neurological_disorders rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029305 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Neurological disorders NEC" ;
                        rdfs:label "neurological disorders" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#One_day_or_less_time_to_onset
:One_day_or_less_time_to_onset rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 1 ;
                               rdfs:label "One day or less time to onset" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Oral_administration
:Oral_administration rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                     rdfs:label "Oral administration" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Orthostatic_hypotension
:Orthostatic_hypotension rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I95.1" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10031127 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Orthostatic hypotension" ;
                         rdfs:label "orthostatic hypotension" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders
:OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders rdf:type owl:NamedIndividual ,
                                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :Reports_for_ivermectin_and_neurological_disorders ;
                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Neurological_disorders ;
                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 156 ;
                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                      rdfs:label "Overall serious reports in Vigibase for Ivermectin for neurological disorders" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 18 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 47 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 28 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient12
:Patient12 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 68 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient13
:Patient13 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 33 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient14
:Patient14 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 81 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient15
:Patient15 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 64 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient16
:Patient16 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 81 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient17
:Patient17 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 59 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient18
:Patient18 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           rdfs:label "Patient 18" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient19
:Patient19 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 24 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 58 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient20
:Patient20 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 75 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient21
:Patient21 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 21" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient22
:Patient22 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 22" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient23
:Patient23 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 56 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient24
:Patient24 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 36 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient25
:Patient25 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 43 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient26
:Patient26 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 11 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient27
:Patient27 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 28 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient28
:Patient28 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 72 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient29
:Patient29 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 97 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 51 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 54 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 32 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 81 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Pharmacokinetics_of_ivermectin
:Pharmacokinetics_of_ivermectin rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                                mp:references :Ref.3 ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ivermectin is not thought to readily cross the bloodbrain barrier in humans, as it is excluded by a Pglycoprotein drug pump (mdr-1). Therefore, it has been considered to be free of the potential to cause neurological adverse drug reactions, except in situations of overdose.3" ;
                                rdfs:label "Pharmacokinetics of ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Product_labelling_for_ivermectin
:Product_labelling_for_ivermectin rdf:type owl:NamedIndividual ,
                                           <http://purl.obolibrary.org/obo/OAE_0001197> ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Structured_Product_Labels_information> ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Conjunctival_hemorrhage ,
                                                                                                           :Difficulty_in_standing ,
                                                                                                           :Difficulty_in_walking ,
                                                                                                           :Fecal_incontinence ,
                                                                                                           :Lethargy ,
                                                                                                           :Mental_status_changes ,
                                                                                                           :Neck_pain ,
                                                                                                           :Red_eye ,
                                                                                                           :Stupor ,
                                                                                                           :Urinary_incontinence ,
                                                                                                           :asthenia ,
                                                                                                           :ataxia ,
                                                                                                           :backPain ,
                                                                                                           :coma ,
                                                                                                           :confusion ,
                                                                                                           :dizziness ,
                                                                                                           :dyspnoea ,
                                                                                                           :encephalopathy ,
                                                                                                           :headache ,
                                                                                                           :paraesthesia ,
                                                                                                           :seizure ,
                                                                                                           :somnolence ,
                                                                                                           :tremor ,
                                                                                                           :vertigo ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                                  mp:references :Ref.1 ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The neurological events of dizziness (2.8%), somnolence (0.9%), vertigo (0.9%), and tremor (0.9%) were observed in human clinical trials for the treatment of strongyloidiasis, while drug-related headache (0.2%) was observed in trials for onchocerciasis; these events are included in the product label. Also included in the labelling is a warning for overdose which can manifest with headache, dizziness, asthenia, seizure, ataxia, and paresthesia.1 The label for ivermectin also provides the following warning: ‚ÄúRarely, patients with onchocerciasis who are also heavily infected with Loa loa may develop a serious or even fatal encephalopathy either spontaneously or following treatment with an effective microfilaricide. In these patients, the following adverse experiences have also been reported: pain (including neck and back pain), red eye, conjunctival hemorrhage, dyspnea, urinary and/or fecal incontinence, difficulty in standing/ walking, mental status changes, confusion, lethargy, stupor, seizures, or coma. This syndrome has been seen very rarely following the use of ivermectin. In individuals who warrant treatment with ivermectin for any reason and have had significant exposure to Loa loa-endemic areas of West or Central Africa, pre-treatment assessment for loiasis and careful post- treatment follow-up should be implemented.‚Äù.1" ;
                                  rdfs:label "Product labelling for ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Public_health_programs_in_Africa
:Public_health_programs_in_Africa rdf:type owl:NamedIndividual ,
                                           <http://purl.obolibrary.org/obo/OAE_0001197> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Neurological_disorders ,
                                                                                                           :coma ,
                                                                                                           :encephalopathy ,
                                                                                                           :neurological_event ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                                  mp:references :Ref.4 ,
                                                :Ref.5 ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Serious neurological adverse events (SNAEs) were initially reported in public health programs in Africa to eliminate onchocerciasis through community-based ivermectin treatment; cases of encephalopathy and coma were reported in Cameroon and the Democratic Republic of Congo in persons who concomitantly harbored high densities of another filarial species, Loa loa. Subsequent analyses revealed a correlation between pre-ivermectin treatment Loa microfilarial density and the risk of developing an SNAE.4,5" ;
                                  rdfs:label "Public health programs in Africa" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Red_eye
:Red_eye rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10038189 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Red eye" ;
         rdfs:label "red eye" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """DailyMed: Product label for ivermectin 
(Stromectol¬Æ). Available from: https:// 
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm? 
setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd. 
Accessed: November 2016.""" ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.10
:Ref.10 rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Macdonald N, Gledhill A. Potential impact of 
ABCB1 (p-glycoprotein) polymorphisms on 
avermectin toxicity in humans. Arch Toxicol. 
2007;81:553. """ ;
        rdfs:label "Ref.10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.11
:Ref.11 rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Bourguinat C, Kamgno J, Boussinesq M, 
MacKenzie CD, Prichard R, Geary TG. 
Analysis of the mdr-1 gene in patients coinfected with Onchocerca volvulus and Loa 
loa who experienced a post-ivermectin 
serious adverse event. Am J Trop Med Hyg. 
2010;83(1):28-32. """ ;
        rdfs:label "Ref.11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Fawcett RS. Ivermectin use in scabies. Am Fam 
Physician. 2003;68(6):1089-92.""" ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Schinkel AH, Smit JJM, van Tellingen O, Beijnen 
JH, Wagenaar E, van Deemter L et al. Disruption 
of the mouse mdr1a-p-glycopretin gene leads to 
a deficiency in the blood- brain barrier and to 
increased sensitivity to drugs. Cell 1994;77:491-502. """ ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Boussinesq M, Gardon J, Gardon-Wendel N, 
Chippaw JP. Clinical picture, epidemiology, and 
outcome of Loa-associated serious adverse 
events related to mass ivermectin treatment of 
onchceriasis in Cameroon. Filiaria J. 2003; 
(Suppl 1): S4. """ ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Gardon J, Gardon-Wendel N, Demanga-Ngangue 
Kamguo J, Chippaux JP, Boussinesq M. Serious 
reactions after mass treatment of onchocerciasis 
with ivermectin in an area endemic for Loa loa 
infections. Lancet 1997;350:18-22. """ ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """ICH Expert Working Group. Post-approval safety 
data management: definitions and standards for 
expedited reporting. 2003. Available from: 
https://www.ich.org/ 
fileadmin/Public_Web_Site/ICH_Products/ 
Guidelines/Efficacy/E2D/Step4/E2D_ 
Guideline.pdf. Accessed: November 2016.""" ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """van Westerloo DJ, Landman GW, Prichard R, 
Lespine A, Visser LG. Persistent coma in 
Strongyloides hyperinfection syndrome 
associated with persistently increased 
ivermectin levels. Clin Infect Dis. 
2014;58(1):143-4. """ ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.8
:Ref.8 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Mealey, KL, Bentjen SA, Gay JM, Cantor GH. 
Ivermectin sensitivity in collies is associated 
with a deletion mutation of the mdr1 gene. 
Pharmacogenetics. 2001;11:727-33.""" ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Ref.9
:Ref.9 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Benet LZ, Cummins CL, Wu CY. Unmasking 
the dynamic interplay between efflux 
transporters and metabolic enzymes. Int J 
Pharm. 2004;277(1-2):3-9.""" ;
       rdfs:label "Ref.9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :headache ,
                                                                                  :lightheadedness ,
                                                                                  :unableToWalk ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report10
:Report10 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :hypoaesthesia ,
                                                                                   :muscleWeakness ,
                                                                                   :paraesthesia ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Piperonyl_butoxide/_esdepallethrime> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report11
:Report11 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :amnesia ,
                                                                                   :confusionalState ,
                                                                                   :emesis ,
                                                                                   :malaise ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report12
:Report12 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :confusionalState ,
                                                                                   :disorderConvulsive ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "no recovery" ;
          rdfs:label "Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report13
:Report13 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :convulsionsGeneralised ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :darunavir ,
                                                                                           :ritonavir ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report14
:Report14 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :cerebellarSyndrome ,
                                                                                   :mentalConfusion ,
                                                                                   :mriAbnormal ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "negative - condition still applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "no recovery" ;
          rdfs:label "Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report15
:Report15 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Strongyloidiasis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo15 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :coma ,
                                                                                   :neurotoxicity ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient15 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report15 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "death" ;
          rdfs:label "Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report16
:Report16 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo16 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :pyrexia ,
                                                                                   :tremor ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :lornoxicam ,
                                                                                     :memantine ,
                                                                                     :rivastigmine ,
                                                                                     :troxipide ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient16 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report16 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset16 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report17
:Report17 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Nematodiasis ,
                                                                                      :Strongyloidiasis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo17 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Orthostatic_hypotension ,
                                                                                   :affectLability ,
                                                                                   :asthenia ,
                                                                                   :asthma ,
                                                                                   :backPain ,
                                                                                   :blood_potassium_decreased ,
                                                                                   :chestPain ,
                                                                                   :chills ,
                                                                                   :confusionalState ,
                                                                                   :constipation ,
                                                                                   :cough ,
                                                                                   :coxsackieVirusTestPositive ,
                                                                                   :dizziness ,
                                                                                   :dysgeusia ,
                                                                                   :dyspnoea ,
                                                                                   :fatigue ,
                                                                                   :feelingAbnormal ,
                                                                                   :feelingCold ,
                                                                                   :feelingDrunk ,
                                                                                   :headache ,
                                                                                   :hypersomnia ,
                                                                                   :hypertension ,
                                                                                   :lossOfConciousness ,
                                                                                   :moodAltered ,
                                                                                   :muscleTwitching ,
                                                                                   :neuralgia ,
                                                                                   :nystagmus ,
                                                                                   :oropharyngealPain ,
                                                                                   :painInExtremity ,
                                                                                   :painInJaw ,
                                                                                   :palpitations ,
                                                                                   :paraesthesia ,
                                                                                   :peripheralColdness ,
                                                                                   :pyrexia ,
                                                                                   :sedation ,
                                                                                   :sensationOfHeaviness ,
                                                                                   :somnolence ,
                                                                                   :tachycardia ,
                                                                                   :thinkingAbnormal ,
                                                                                   :tremor ,
                                                                                   :vertigo ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :ascorbicAcid ,
                                                                                     :colesevelam ,
                                                                                     :desvenlafaxine ,
                                                                                     :doxycycline ,
                                                                                     :levothyroxine ,
                                                                                     :melatonin ,
                                                                                     :montelukast ,
                                                                                     :olopatadine ,
                                                                                     :omega-3 ,
                                                                                     :pioglitazone ,
                                                                                     :potassiumCitrate ,
                                                                                     :prasterone ,
                                                                                     :probiotics ,
                                                                                     :progesterone ,
                                                                                     :vitaminD ,
                                                                                     :vitamins ,
                                                                                     <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#formoterol/budesonide> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_medication_error> :inappropriateScheduleOfDrugAdministration ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient17 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report17 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset17 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "negative - condition still applied" ;
          rdfs:label "Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report18
:Report18 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :seizure ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :levetiracetam ,
                                                                                     :valproicAcid ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_medication_error> :offLabelUse ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient18 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report18 ;
          rdfs:label "Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report19
:Report19 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo19 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :cephalgia ,
                                                                                   :confusion ,
                                                                                   :convulsiveDisorder ,
                                                                                   :fall ,
                                                                                   :fatigue ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient19 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report19 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :oxatomide ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset19 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after hospitalization" ;
          rdfs:label "Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :consciousnessDisturbed ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :alprazolam ,
                                                                                    :etizolam ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report20
:Report20 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Taeniasis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo20 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :asthenia ,
                                                                                   :dizziness ,
                                                                                   :dyspnoea ,
                                                                                   :paraesthesia ,
                                                                                   :visionDecreased ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :amlodipine ,
                                                                                     :clopidogrel ,
                                                                                     :lisinopril ,
                                                                                     :metoprolol ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient20 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report20 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset20 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with sequelae" ;
          rdfs:label "Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report21
:Report21 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo21 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :confusionalState ,
                                                                                   :unconsciousness ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :amantidine ,
                                                                                     :haloperidol ,
                                                                                     :hydroxyzine ,
                                                                                     :lorazepam ,
                                                                                     :ranitidine ,
                                                                                     :risperidone ,
                                                                                     :toprimate ,
                                                                                     :trazadone ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient21 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report21 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "hospitalization for treatment" ;
          rdfs:label "Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report22
:Report22 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Strongyloidiasis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :qualityOfLifeDecreased ,
                                                                                   :sleepDisorder ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient22 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report22 ;
          rdfs:label "Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report23
:Report23 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo23 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Urine_odour_abnormal ,
                                                                                   :abnormalFaeces ,
                                                                                   :alopecia ,
                                                                                   :aphasia ,
                                                                                   :dryMouth ,
                                                                                   :dyspnoea ,
                                                                                   :earInfection ,
                                                                                   :flushing ,
                                                                                   :gastrointestinalMotilityDisorder ,
                                                                                   :headache ,
                                                                                   :heartRateIncreased ,
                                                                                   :lipSwelling ,
                                                                                   :musculoskeletalDiscomfort ,
                                                                                   :oralDiscomfort ,
                                                                                   :redBloodCellCountDecreased ,
                                                                                   :somaticDelusion ,
                                                                                   :swollenTongue ,
                                                                                   :urineColourAbnormal ,
                                                                                   :weightDecreased ,
                                                                                   :whiteBloodCellCountDecreased ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :amoxicillin ,
                                                                                     :azathioprine ,
                                                                                     :dexlansoprazole ,
                                                                                     :diazepam ,
                                                                                     :furosemide ,
                                                                                     :gabapentin ,
                                                                                     :hydrochloroquine ,
                                                                                     :lansoprazole ,
                                                                                     :levothyroxine ,
                                                                                     :lisinopril ,
                                                                                     :meloxicam ,
                                                                                     :milnacipran ,
                                                                                     :nortriptyline ,
                                                                                     :predinose ,
                                                                                     :promethazine ,
                                                                                     :propranolol ,
                                                                                     :trazadone ,
                                                                                     :vitaminD ,
                                                                                     :vitamins ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient23 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report23 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :terbinafine ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset23 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "negative - condition still applied" ;
          rdfs:label "Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report24
:Report24 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo24 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :abdominalDiscomfort ,
                                                                                   :diarrhoea ,
                                                                                   :headache ,
                                                                                   :vomiting ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient24 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report24 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :albendazole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset24 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report25
:Report25 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo25 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :dizziness ,
                                                                                   :headache ,
                                                                                   :vomiting ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient25 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report25 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :albendazole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset25 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report26
:Report26 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo26 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :dizziness ,
                                                                                   :headache ,
                                                                                   :vomiting ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient26 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report26 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :albendazole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset26 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report27
:Report27 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo27 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :unconsciousness ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :amoxicillin ,
                                                                                     :diclofenac ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient27 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report27 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :albendazole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset27 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after hospitalization" ;
          rdfs:label "Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report28
:Report28 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo28 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :abdominalDiscomfort ,
                                                                                   :headache ,
                                                                                   :itching ,
                                                                                   :oedema ,
                                                                                   :vomiting ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient28 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report28 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :albendazole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset28 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery with no further information" ;
          rdfs:label "Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report29
:Report29 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo29 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :depressedLevelOfConsciousness ,
                                                                                   :lossOfConciousness ,
                                                                                   :vomiting ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :carbocisteine ,
                                                                                     :etizolam ,
                                                                                     :febuxostat ,
                                                                                     :furosemide ,
                                                                                     :lansoprazole ,
                                                                                     :magnesiumOxide ,
                                                                                     <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sennosidea+b> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient29 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report29 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset29 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Myiasis ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :seizure ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_medication_error> :offLabelUse ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "no recovery" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :abasia ,
                                                                                  :aphasia ,
                                                                                  :blindness ,
                                                                                  :diseaseRecurrence ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :ariprazole ,
                                                                                    :docusate ,
                                                                                    :lamotrigine ,
                                                                                    :meloxicam ,
                                                                                    :pregabalin ,
                                                                                    :simvastatin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_rechallenge_outcome> "positive rechallenge - condition appeared again" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :confusionalState ,
                                                                                  :convulsion ,
                                                                                  :headache ,
                                                                                  :heartRateIncreased ,
                                                                                  :localSwelling ,
                                                                                  :nausea ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient5 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report5 ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :abdominalPainLower ,
                                                                                  :dizzySpells ,
                                                                                  :mucosalDryness ,
                                                                                  :tremor ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient6 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report6 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset6 ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo7 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :asphyxia ,
                                                                                  :depressedLevelOfConsciousness ,
                                                                                  :pruritus ,
                                                                                  :skinEruption ,
                                                                                  :vomiting ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :crotamiton ,
                                                                                    :digoxin ,
                                                                                    :magnesiumOxide ,
                                                                                    :rebamipide ,
                                                                                    :senna ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient7 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report7 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset7 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "death" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :coma ,
                                                                                  :emesis ,
                                                                                  :encephalopathy ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :AdditionalInfo9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :chills ,
                                                                                  :cryingAbnormal ,
                                                                                  :dizziness ,
                                                                                  :monoparesis ,
                                                                                  :rigors ,
                                                                                  :tremor ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :ivermectin_usage_for_Report9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> <http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Piperonyl_butoxide/_esdepallethrime> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :TimeToOnset9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ReportsFromAfrica
:ReportsFromAfrica rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 95 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 15 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 13 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 97 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 11 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Africa" ;
                   rdfs:label "Reports from Africa" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ReportsFromAmericas
:ReportsFromAmericas rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 32 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Americas" ;
                     rdfs:label "Reports from Americas" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ReportsFromEurope
:ReportsFromEurope rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 19 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Europe" ;
                   rdfs:label "Reports from Europe" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ReportsWithFatalOutcome
:ReportsWithFatalOutcome rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "death" ;
                         rdfs:label "Reports with fatal outcome" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ReportsWithPositiveDechallenge
:ReportsWithPositiveDechallenge rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 9 ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
                                rdfs:label "Reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_for_ivermectin
:Reports_for_ivermectin rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1668 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                        rdfs:label "Reports for ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_for_ivermectin_and_dizziness
:Reports_for_ivermectin_and_dizziness rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :Reports_for_ivermectin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :dizziness ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 125 ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                      rdfs:label "Reports for ivermectin and dizziness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_for_ivermectin_and_headache
:Reports_for_ivermectin_and_headache rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :Reports_for_ivermectin ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :headache ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 232 ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                     rdfs:label "Reports for ivermectin and headache" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_for_ivermectin_and_neurological_disorders
:Reports_for_ivermectin_and_neurological_disorders rdf:type owl:NamedIndividual ,
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :Reports_for_ivermectin ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Neurological_disorders ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 426 ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                   rdfs:label "Reports for ivermectin and neurological disorders" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_for_ivermectin_and_pruritus
:Reports_for_ivermectin_and_pruritus rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :Reports_for_ivermectin ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :pruritus ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 422 ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                     rdfs:label "Reports for ivermectin and pruritus" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_from_case_series
:Reports_from_case_series rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 29 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 15 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 13 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 97 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 11 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                          rdfs:label "Reports from case series" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_in_VigiBase
:Reports_in_VigiBase rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                     mp:references :Ref.7 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """All reports for ivermectin received into VigiBase up to 27 November 2016 were identified for investigation. A total of 1,668 reports for ivermectin were identified. The most commonly reported adverse events (AEs) for ivermectin were pruritus (25.3%), headache (13.9%) and dizziness (7.5%). Under the MedDRA System Organ Class ‚ÄúNeurological disorders‚Äù 426 reports were classified, and 156 of these were classified as ‚Äúserious‚Äù according to ICH Guidance.6 Of the serious reports, 60.9% (95) of them originated from Africa, 20.5% (32) from the Americas, 12.2% (19) from Europe, and 6.4% (10) from Asia. One duplicate report was identified and excluded from the analysis. Sixty-four of the 155 serious reports described the use of ivermectin for O. volvulus. Forty-two did not include an indication; one reported only ‚Äúinfection parasitic‚Äù. After clinical analysis, nineteen reports were excluded from this analysis: the reasons for exclusion were neurological AEs reported in the context of other clinical syndromes (lactic acidosis/ circulatory collapse, cerebral infarction/ cerebral artery embolism, neuroleptic malignant syndrome, hepatitis/hepatic failure, brain cancer, pneumonia with hypotension, accidental exposure to product, sepsis complicating chemotherapy, multi-organ failure, history of epilepsy, Alzheimer‚Äôs disease), topical ivermectin for rosacea, prolonged time to onset of ivermectin (8 years), and unclear onset of symptoms in relation to ivermectin. The remaining 29 reports are included in this case series and were received from, Canada France, Germany, Japan, the Netherlands, Sierra Leone, and the United States. The patient ages were mentioned in 25 reports and ranged from 11 to 97 years. Fifteen described males, 13 described females and the gender was not provided in one report. Scabies was included as an indication in eleven reports, acarodermatitis in eight, filariasis due to Wucheria bancrofti in five, strongyloidiasis in three, taeniasis in one and myiasis in one. The time to onset of the SNAEs ranged from hours to 14 days, with 14 cases noting a time to onset of one day or less. As seen in Table 1, examples of serious ADRs reported include unable to walk, consciousness disturbed or depressed level of consciousness or loss of consciousness, seizure or convulsion, encephalopathy or coma, and tremor. The dosages of ivermectin ranged between 3 mg and 24 mg. Most of the cases reported a one-time dose or two doses separated by one week. Weight information was provided for the majority of cases, and there was no suggestion of overdose based on the data provided. Nine reports documented a positive dechallenge, with resolution of symptoms after discontinuing ivermectin. One documented a positive rechallenge, with recurrence of symptoms with re-exposure on two occasions. Two patients died. One case has been previously published, and documented the presence of ivermectin in brain tissue: ‚ÄúA 64-year-old male with a past medical history of giant cell arteritis, treated with prednisone developed sepsis, complicated by multisystem organ failure, after an aortic valve replacement. Sputum culture revealed S. 
stercoralis. A diagnosis of S. stercoralis hyperinfection syndrome was made; he was initiated on ivermectin 12 mg every 48 hours. He received three oral doses followed by two subcutaneous doses. In spite of clinical and microbiological improvement, the patient remained in a vegetative state and died on day 25. Autopsy revealed an elevated level of ivermectin in the brain tissue, 14 days after the last dose.‚Äù.7""" ;
                     rdfs:label "Reports in VigiBase" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_acarodermatitis_as_indication
:Reports_with_acarodermatitis_as_indication rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Acarodermatitis ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 8 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                            rdfs:label "Reports with acarodermatitis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_filariasis_as_indication
:Reports_with_filariasis_as_indication rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :FilariasisDueToWuchereriaBancrofti ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 5 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "Reports with filariasis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_myiasis_as_indication
:Reports_with_myiasis_as_indication rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Myiasis ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                    rdfs:label "Reports with myiasis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_positive_rechallenge
:Reports_with_positive_rechallenge rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_rechallenge_outcome> "positive rechallenge - condition appeared again" ;
                                   rdfs:label "Reports with positive rechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_scabies_as_indication
:Reports_with_scabies_as_indication rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :scabies ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 11 ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                    rdfs:label "Reports with scabies as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_strongyloidiasis_as_indication
:Reports_with_strongyloidiasis_as_indication rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Strongyloidiasis ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 3 ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                             rdfs:label "Reports with strongyloidiasis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reports_with_taeniasis_as_indication
:Reports_with_taeniasis_as_indication rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Taeniasis ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                      rdfs:label "Reports with taeniasis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reprots_with_O._volvulus_as_indication
:Reprots_with_O._volvulus_as_indication rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :onchocerciasis ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 64 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                        rdfs:label "Reports with O. volvulus as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Reprots_with_parasitic_infection_as_indication
:Reprots_with_parasitic_infection_as_indication rdf:type owl:NamedIndividual ,
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Infection_parasitic ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                rdfs:label "Reports with parasitic infection as indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#RreportsFromAsia
:RreportsFromAsia rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 10 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_geographical_region> "http://dbpedia.org/resource/Asia" ;
                  rdfs:label "Reports from Asia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Strongyloidiasis
:Strongyloidiasis rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B78" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042254 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Strongyloidiasis" ;
                  rdfs:label "strongyloidiasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Stupor
:Stupor rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R40.1" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042264 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Stupor" ;
        rdfs:label "stupor" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Subcutaneous_administration
:Subcutaneous_administration rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "subcutaneous" ;
                             rdfs:label "Subcutaneous administration" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Suggested_AE_Mechanism_regarding_CYP3A4
:Suggested_AE_Mechanism_regarding_CYP3A4 rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect_Mechanism> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Neurological_disorders ,
                                                                                                                  :neurological_event ;
                                         mp:references :Ref.9 ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A number of cases included in the case series may be related to concomitantly administered drugs. Drugs that are substrates of CYP3A4 enzymes are often also substrates for Pglycoprotein transport, and thus there may be a risk of increased absorption past the bloodbrain barrier with concomitant adminstration.9 Several cases presented here reported concomitant use of such drugs, such as statins, HIV protease inhibitors, calcium channel blockers, and benzodiazepines. Current labelling for ivermectin contains no warning for co-administration with CYP3A4 substrates" ;
                                         rdfs:label "Suggested AE Mechanism regarding CYP3A4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Suggested_AE_Mechanism_regarding_Mdr-1_gene
:Suggested_AE_Mechanism_regarding_Mdr-1_gene rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect_Mechanism> ;
                                             mp:references :Ref.10 ,
                                                           :Ref.11 ,
                                                           :Ref.8 ,
                                                           :Ref.9 ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Another possible explanation is that some humans experiencing an SNAE after ivermectin therapy may also have mutations in the mdr-1 gene, allowing for penetration of ivermectin into the central nervous system. More than 50 naturally occurring single nucleotide polymorphisms (SNP) have been identified in the mdr-1 gene; the majority of these SNP are silent, and there is no current evidence of a mutation that results in loss of function. However, various combinations of these SNP, comprising different P-glycoprotein haplotypes, have been found to exhibit reduced mdr-1 expression.10 Bourguinat et al performed a study in which they analysed mdr-1 genotypes in 13 subjects from Cameroon: four who experienced a serious adverse event and nine who did not. Haplotypes associated with altered drug disposition were present as homozygotes in two of the serious AE patients and in none of the control patients.11 One of the cases in our series was investigated for the most common polymorphisms associated with decreased mdr-1 expression and found that none were present; however, further details were not provided.8" ,
                                                                                                         "a loss of function in the mdr-1 gene in these breeds allows for an accumulation of ivermectin within the brain.8" ;
                                             rdfs:label "Suggested AE Mechanism regarding Mdr-1 gene" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Taeniasis
:Taeniasis rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B68" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043095 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Taeniasis" ;
           rdfs:label "taeniasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset1
:TimeToOnset1 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1 day " ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 1 ;
              rdfs:label "Time to onset 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset10
:TimeToOnset10 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "7 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 7 ;
               rdfs:label "Time to onset 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset11
:TimeToOnset11 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1 day " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset12
:TimeToOnset12 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "14 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 14 ;
               rdfs:label "Time to onset 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset13
:TimeToOnset13 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1 day " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset14
:TimeToOnset14 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "2 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 2 ;
               rdfs:label "Time to onset 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset16
:TimeToOnset16 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset17
:TimeToOnset17 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1-2 days" ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericDuration> 1 ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset19
:TimeToOnset19 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset2
:TimeToOnset2 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 0 ;
              rdfs:label "Time to onset 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset20
:TimeToOnset20 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset23
:TimeToOnset23 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "2-5 days for aphasia and somatic delusion" ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericDuration> 3 ;
               <http://www.w3.org/2006/time#numericPosition> 2 ;
               rdfs:label "Time to onset 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset24
:TimeToOnset24 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1 day " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 1 ;
               rdfs:label "Time to onset 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset25
:TimeToOnset25 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "2 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 2 ;
               rdfs:label "Time to onset 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset26
:TimeToOnset26 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset27
:TimeToOnset27 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset28
:TimeToOnset28 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "0 days " ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 0 ;
               rdfs:label "Time to onset 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset29
:TimeToOnset29 rdf:type owl:NamedIndividual ,
                        <http://www.w3.org/2006/time#DurationDescription> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "6 days after 1st dose and 5 days after 2nd dose" ;
               <http://www.w3.org/2006/time#nominalPosition> "days" ;
               <http://www.w3.org/2006/time#numericPosition> 5 ,
                                                             6 ;
               rdfs:label "Time to onset 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset6
:TimeToOnset6 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "8 hours " ;
              <http://www.w3.org/2006/time#nominalPosition> "hours" ;
              <http://www.w3.org/2006/time#numericPosition> 8 ;
              rdfs:label "Time to onset 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset7
:TimeToOnset7 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 days after last dose" ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 5 ;
              rdfs:label "Time to onset 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset8
:TimeToOnset8 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1 day " ;
              <http://www.w3.org/2006/time#nominalPosition> "days" ;
              <http://www.w3.org/2006/time#numericPosition> 1 ;
              rdfs:label "Time to onset 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#TimeToOnset9
:TimeToOnset9 rdf:type owl:NamedIndividual ,
                       <http://www.w3.org/2006/time#DurationDescription> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "10 hours " ;
              <http://www.w3.org/2006/time#nominalPosition> "hours" ;
              <http://www.w3.org/2006/time#numericPosition> 10 ;
              rdfs:label "Time to onset 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Uppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/ns/prov#Organization> ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Urinary_incontinence
:Urinary_incontinence rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R32" ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10046543 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Urinary incontinence" ;
                      rdfs:label "urinary incontinence" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Urine_odour_abnormal
:Urine_odour_abnormal rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10057135 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Urine odour abnormal" ;
                      rdfs:label "urine odour abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#abasia
:abasia rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F44.4" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10017581 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gait inability" ;
        rdfs:label "abasia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#abdominalDiscomfort
:abdominalDiscomfort rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R10.9" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10000059 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Abdominal discomfort" ;
                     rdfs:label "abdominal discomfort" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#abdominalPainLower
:abdominalPainLower rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R10.3" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10000084 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Abdominal pain lower" ;
                    rdfs:label "abdominal pain lower" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#abnormalFaeces
:abnormalFaeces rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R19.5" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10000133 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Abnormal faeces	" ;
                rdfs:label "abnormal faeces" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#affectLability
:affectLability rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R45.86" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10054196 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Affect lability" ;
                rdfs:label "affect lability" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#albendazole
:albendazole rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "P02CA03" ;
             rdfs:label "albendazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#alopecia
:alopecia rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L65.9" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10001760 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Alopecia" ;
          rdfs:label "alopecia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#alprazolam
:alprazolam rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA12" ;
            rdfs:label "alprazolam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#amantidine
:amantidine rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N04BB01" ;
            rdfs:label "amantidine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#amlodipine
:amlodipine rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C08CA01" ;
            rdfs:label "amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#amnesia
:amnesia rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R41.3" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10001949 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Amnesia" ;
         rdfs:label "amnesia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#amoxicillin
:amoxicillin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01CA04" ;
             rdfs:label "amoxicillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#aphasia
:aphasia rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R47.0" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10002948 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Aphasia" ;
         rdfs:label "aphasia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ariprazole
:ariprazole rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05AX12" ;
            rdfs:label "ariprazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ascorbicAcid
:ascorbicAcid rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G01AD03" ;
              rdfs:label "ascorbic acid" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#asphyxia
:asphyxia rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R09.0" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003497 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Asphyxia" ;
          rdfs:label "asphyxia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#asthenia
:asthenia rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R53" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003549 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Asthenia" ;
          rdfs:label "asthenia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#asthma
:asthma rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J45" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003553 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Asthma" ;
        rdfs:label "asthma" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ataxia
:ataxia rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R27.0" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003591 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Ataxia" ;
        rdfs:label "ataxia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#azathioprine
:azathioprine rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "L04AX01" ;
              rdfs:label "azathioprine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#backPain
:backPain rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M54" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003988 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Back pain" ;
          rdfs:label "back pain" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#benzodiazepines
:benzodiazepines rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Suggested_AE_Mechanism_regarding_CYP3A4 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA" ;
                 rdfs:label "benzodiazepines" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#blindness
:blindness rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "H54" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005184 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "blindness" ;
           rdfs:label "blindness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#blood_potassium_decreased
:blood_potassium_decreased rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "E87.6" ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005724 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Blood potassium decreased" ;
                           rdfs:label "blood potassium decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#budesonide
:budesonide rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R01AD05 " ;
            rdfs:label "budesonide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#calcium_channel_blockers
:calcium_channel_blockers rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Suggested_AE_Mechanism_regarding_CYP3A4 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C08" ;
                          rdfs:label "calcium channel blockers" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#carbocisteine
:carbocisteine rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R05CB03" ;
               rdfs:label "carbocisteine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#cephalgia
:cephalgia rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R51" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10019211 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Headache" ;
           rdfs:label "cephalgia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#cerebellarSyndrome
:cerebellarSyndrome rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I67.9" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008072 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cerebellar syndrome" ;
                    rdfs:label "cerebellar syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#chestPain
:chestPain rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R07" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008479 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chest pain" ;
           rdfs:label "chest pain" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#chills
:chills rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R68.8" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008531 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chills" ;
        rdfs:label "chills" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#clopidogrel
:clopidogrel rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "B01AC04" ;
             rdfs:label "clopidogrel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#colesevelam
:colesevelam rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C10AC04" ;
             rdfs:label "colesevelam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#coma
:coma rdf:type owl:NamedIndividual ,
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R40" ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010071 ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Coma" ;
      rdfs:label "coma" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#confusion
:confusion rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F44.8" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010305 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Confusional state" ;
           rdfs:label "confusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#confusionalState
:confusionalState rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F44.8" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010305 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Confusional state" ;
                  rdfs:label "confusional state" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#consciousnessDisturbed
:consciousnessDisturbed rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R41.82" ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10001854 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Altered state of consciousness" ;
                        rdfs:label "consciousness disturbed" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#constipation
:constipation rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "K59.0" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010774 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Constipation" ;
              rdfs:label "constipation" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#convulsion
:convulsion rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R56" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039906 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Seizure" ;
            rdfs:label "convulsion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#convulsionsGeneralised
:convulsionsGeneralised rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R56.8" ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010916 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Convulsions generalised	" ;
                        rdfs:label "convulsions generalised" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#convulsiveDisorder
:convulsiveDisorder rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R56.8" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039906 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Seizure" ;
                    rdfs:label "convulsive disorder" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#cough
:cough rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R05" ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011224 ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cough" ;
       rdfs:label "cough" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#coxsackieVirusTestPositive
:coxsackieVirusTestPositive rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B34.1" ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10070384 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Coxsackie virus test positive" ;
                            rdfs:label "coxsackie  virus test positive" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#crotamiton
:crotamiton rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "D04AX" ;
            rdfs:label "crotamiton" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#cryingAbnormal
:cryingAbnormal rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R45.83" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011469 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Crying" ;
                rdfs:label "crying abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#darunavir
:darunavir rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J05AE10	" ;
           rdfs:label "darunavir" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#depressedLevelOfConsciousness
:depressedLevelOfConsciousness rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R41.82" ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012373 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Depressed level of consciousness" ;
                               rdfs:label "depressed level of consciousness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#desvenlafaxine
:desvenlafaxine rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AX23" ;
                rdfs:label "desvenlafaxine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dexlansoprazole
:dexlansoprazole rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BC06" ;
                 rdfs:label "dexlansoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#diarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R19.7" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012735 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#diazepam
:diazepam rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA01" ;
          rdfs:label "diazepam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#diclofenac
:diclofenac rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "D11AX18" ;
            rdfs:label "diclofenac" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#digoxin
:digoxin rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01AA05" ;
         rdfs:label "digoxin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#diseaseRecurrence
:diseaseRecurrence rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N02.6" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10061819 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Disease recurrence" ;
                   rdfs:label "disease recurrence" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#disorderConvulsive
:disorderConvulsive rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R56.8" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039906 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Seizure" ;
                    rdfs:label "disorder convulsive" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dizziness
:dizziness rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R42" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013573 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dizziness" ;
           rdfs:label "dizziness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dizzySpells
:dizzySpells rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R42" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013573 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dizziness" ;
             rdfs:label "dizzy spells" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#docusate
:docusate rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A06AA02" ;
          rdfs:label "docusate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#doxycycline
:doxycycline rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A01AB22" ;
             rdfs:label "doxycycline" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dryMouth
:dryMouth rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R68.2" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013781 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dry mouth	" ;
          rdfs:label "dry mouth" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dysgeusia
:dysgeusia rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R43.2" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013911 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dysgeusia" ;
           rdfs:label "dysgeusia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#dyspnoea
:dyspnoea rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R06.0" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013968 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dyspnoea" ;
          rdfs:label "dyspnoea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#earInfection
:earInfection rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "H60" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10014011 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Ear infection	" ;
              rdfs:label "ear infection" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#emesis
:emesis rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R11" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047700 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Vomiting" ;
        rdfs:label "emesis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#encephalopathy
:encephalopathy rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G93.4" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10014625 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Encephalopathy" ;
                rdfs:label "encephalopathy" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#etizolam
:etizolam rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA19" ;
          rdfs:label "etizolam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#fall
:fall rdf:type owl:NamedIndividual ,
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "XXXA¬†" ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016173 ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Fall" ;
      rdfs:label "fall" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#fatigue
:fatigue rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R53" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016256 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#febuxostat
:febuxostat rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "M04AA03" ;
            rdfs:label "febuxostat" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#feelingAbnormal
:feelingAbnormal rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R68.89" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016322 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Feeling abnormal" ;
                 rdfs:label "feeling abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#feelingCold
:feelingCold rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R68.83" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016326 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Feeling cold" ;
             rdfs:label "feeling cold" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#feelingDrunk
:feelingDrunk rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R45.4" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016330 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Feeling drunk" ;
              rdfs:label "feeling drunk" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#filariasisDueToWuchereriaBancrofti
:filariasisDueToWuchereriaBancrofti rdf:type owl:NamedIndividual ;
                                    rdfs:label "filariasisDueToWuchereriaBancrofti" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#flushing
:flushing rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R23.2" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10016825 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Flushing" ;
          rdfs:label "flushing" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03CA01" ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#gabapentin
:gabapentin rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX12" ;
            rdfs:label "gabapentin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#gastrointestinalMotilityDisorder
:gastrointestinalMotilityDisorder rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R23.2" ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10061173 ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gastrointestinal motility disorder" ;
                                  rdfs:label "gastrointestinal motility disorder" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#haloperidol
:haloperidol rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05AD01" ;
             rdfs:label "haloperidol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#headache
:headache rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R51" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10019211 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Headache" ;
          rdfs:label "headache" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#heartRateIncreased
:heartRateIncreased rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R00.0" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10019303 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Heart rate increased" ;
                    rdfs:label "heart rate increased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hiv_protease_inhibtors
:hiv_protease_inhibtors rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Suggested_AE_Mechanism_regarding_CYP3A4 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J05AE" ;
                        rdfs:label "hiv protease inhibtors" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hydrochloroquine
:hydrochloroquine rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "P01BA02 " ;
                  rdfs:label "hydrochloroquine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hydroxyzine
:hydroxyzine rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BB01" ;
             rdfs:label "hydroxyzine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hypersomnia
:hypersomnia rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G47.8" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020765 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypersomnia" ;
             rdfs:label "hypersomnia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hypertension
:hypertension rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I10" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020772 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypertension" ;
              rdfs:label "hypertension" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#hypoaesthesia
:hypoaesthesia rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R20.1" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020937 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypoaesthesia" ;
               rdfs:label "hypoaesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#inappropriateScheduleOfDrugAdministration
:inappropriateScheduleOfDrugAdministration rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Medication_Errors> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10081572 ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Inappropriate schedule of product administration" ;
                                           rdfs:label "inappropriate schedule of drug administration" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#introduction
:introduction rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction> ;
              mp:references :Ref.1 ,
                            :Ref.2 ,
                            :Ref.3 ,
                            :Ref.4 ,
                            :Ref.5 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ivermectin is a member of the class of avermectins, which are highly active broad-spectrum, antiparasitic agents. It is indicated for use in the treatment of strongyloidiasis (Strongyloides stercoralis) and onchocerciasis (Onchocerca volvulus); however, it is also commonly used to treat scabies, in circumstances such as immunocompromised patients, when topical therapy has failed, or institutionalized patients.1,2 Ivermectin is not thought to readily cross the bloodbrain barrier in humans, as it is excluded by a Pglycoprotein drug pump (mdr-1). Therefore, it has been considered to be free of the potential to cause neurological adverse drug reactions, except in situations of overdose.3 Serious neurological adverse events (SNAEs) were initially reported in public health programs in Africa to eliminate onchocerciasis through community based ivermectin treatment; cases of encephalopathy and coma were reported in Cameroon and the Democratic Republic of Congo in persons who concomitantly harbored high densities of another filarial species, Loa loa. Subsequent analyses revealed a correlation between preivermectin treatment Loa microfilarial density and the risk of developing an SNAE.4,5 In September 2015, a signal detection screening of VigiBase, the WHO global database of individual case safety reports, was performed focussing on drug-event combinations sensitive to reporting patterns mainly in Africa, Asia and Latin America and the Caribbean. During this screening a report for an SNAE (ataxia) from the Democratic Republic of the Congo was identified, which stated ‚ÄúThis patient of 56-year old realises these conditions [encephalopathy]. It is very surprising to notice that there was no microfilariae in the calibrated thick blood smear.‚Äù The lack of evidence of a high density of L. loa appeared to challenge the literature on SNAEs with ivermectin, and therefore it triggered a review of all SNAEs beyond the indication of use for onchocerciasis which could not be explained by concomitant infection with L. loa." ;
              rdfs:label "introduction" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#itching
:itching rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L29" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037087 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pruritus" ;
         rdfs:label "itching" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin
:ivermectin rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#hasClass> :Avermectins ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Ivermectin_mechanism ,
                                                                          :Pharmacokinetics_of_ivermectin ,
                                                                          :Suggested_AE_Mechanism_regarding_Mdr-1_gene ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "P02CF01" ;
            rdfs:label "ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report1
:ivermectin_usage_for_Report1 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage1 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report10
:ivermectin_usage_for_Report10 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage10 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report11
:ivermectin_usage_for_Report11 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage11 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report12
:ivermectin_usage_for_Report12 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage12 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report13
:ivermectin_usage_for_Report13 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage13 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report14
:ivermectin_usage_for_Report14 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage14 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report15
:ivermectin_usage_for_Report15 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Oral_administration ,
                                                                                                           :Subcutaneous_administration ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage15 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report16
:ivermectin_usage_for_Report16 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage16 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report17
:ivermectin_usage_for_Report17 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage17 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report18
:ivermectin_usage_for_Report18 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report19
:ivermectin_usage_for_Report19 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage19 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report2
:ivermectin_usage_for_Report2 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage2 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report20
:ivermectin_usage_for_Report20 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage20 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report21
:ivermectin_usage_for_Report21 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage21 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report22
:ivermectin_usage_for_Report22 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage22 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report23
:ivermectin_usage_for_Report23 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage23 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report24
:ivermectin_usage_for_Report24 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage24 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report25
:ivermectin_usage_for_Report25 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage25 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report26
:ivermectin_usage_for_Report26 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage26 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report27
:ivermectin_usage_for_Report27 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage27 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report28
:ivermectin_usage_for_Report28 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage28 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report29
:ivermectin_usage_for_Report29 rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage29 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                               rdfs:label "Usage for Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report3
:ivermectin_usage_for_Report3 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage3 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report4
:ivermectin_usage_for_Report4 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage4 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report5
:ivermectin_usage_for_Report5 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage5 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report6
:ivermectin_usage_for_Report6 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage6 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report7
:ivermectin_usage_for_Report7 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage7 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report8
:ivermectin_usage_for_Report8 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage8 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ivermectin_usage_for_Report9
:ivermectin_usage_for_Report9 rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Dosage9 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                              rdfs:label "Usage for Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lamotrigine
:lamotrigine rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX09" ;
             rdfs:label "lamotrigine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lansoprazole
:lansoprazole rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BC03" ;
              rdfs:label "lansoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#levetiracetam
:levetiracetam rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX14" ;
               rdfs:label "levetiracetam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#levothyroxine
:levothyroxine rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "H03AA01" ;
               rdfs:label "levothyroxine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lightheadedness
:lightheadedness rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R42" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013573 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dizziness" ;
                 rdfs:label "lightheadedness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lipSwelling
:lipSwelling rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R22.0" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10024570 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Lip swelling" ;
             rdfs:label "lip swelling" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C09AA03" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#localSwelling
:localSwelling rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R22" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042674 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Swelling" ;
               rdfs:label "local swelling" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lorazepam
:lorazepam rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA06" ;
           rdfs:label "lorazepam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lornoxicam
:lornoxicam rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "M01AC05" ;
            rdfs:label "lornoxicam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#lossOfConciousness
:lossOfConciousness rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R55¬†" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10024855 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Loss of consciousness" ;
                    rdfs:label "loss of conciousness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#magnesiumOxide
:magnesiumOxide rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02AA02" ;
                rdfs:label "magnesium oxide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#malaise
:malaise rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R53" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10025482 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Malaise" ;
         rdfs:label "malaise" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#melatonin
:melatonin rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05CH01" ;
           rdfs:label "melatonin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#meloxicam
:meloxicam rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "M01AC06" ;
           rdfs:label "meloxicam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#memantine
:memantine rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06DX01" ;
           rdfs:label "memantine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#mentalConfusion
:mentalConfusion rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F44.8" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10010305 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Confusional state" ;
                 rdfs:label "mental confusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#metoprolol
:metoprolol rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C07AB02" ;
            rdfs:label "metoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#milnacipran
:milnacipran rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AX17" ;
             rdfs:label "milnacipran" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#monoparesis
:monoparesis rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G83.10" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10027925 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Monoparesis" ;
             rdfs:label "monoparesis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#montelukast
:montelukast rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R03DC03" ;
             rdfs:label "montelukast" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#moodAltered
:moodAltered rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F39" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10027940 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "mood altered" ;
             rdfs:label "mood altered" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#mriAbnormal
:mriAbnormal rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R93.5" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029816 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nuclear magnetic resonance imaging abnormal" ;
             rdfs:label "mri abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#mucosalDryness
:mucosalDryness rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028111 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Mucosal dryness" ;
                rdfs:label "mucosal dryness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#muscleTwitching
:muscleTwitching rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M62.838" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028347 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Muscle twitching" ;
                 rdfs:label "muscle twitching" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#muscleWeakness
:muscleWeakness rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M62.8" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028372 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Muscular weakness" ;
                rdfs:label "muscle weakness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#musculoskeletalDiscomfort
:musculoskeletalDiscomfort rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M79.1" ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10053156 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Musculoskeletal discomfort" ;
                           rdfs:label "musculoskeletal discomfort" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#nausea
:nausea rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R11" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028813 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nausea" ;
        rdfs:label "nausea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#neuralgia
:neuralgia rdf:type owl:NamedIndividual ;
           rdfs:label "neuralgia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#neurological_complication
:neurological_complication rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029202 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nervous system disorder" ;
                           rdfs:label "neurological complication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#neurological_event
:neurological_event rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029298 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Neurological disorder NOS" ;
                    rdfs:label "neurological event" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#neurotoxicity
:neurotoxicity rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029350 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Neurotoxicity" ;
               rdfs:label "neurotoxicity" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#nortriptyline
:nortriptyline rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AA10" ;
               rdfs:label "nortriptyline" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#nystagmus
:nystagmus rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "H55" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029864 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nystagmus" ;
           rdfs:label "nystagmus" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#oedema
:oedema rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R60" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10030095 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Oedema" ;
        rdfs:label "oedema" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#offLabelUse
:offLabelUse rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Medication_Errors> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10053762 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Off label use" ;
             rdfs:label "off label use" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#olopatadine
:olopatadine rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R01AC08" ;
             rdfs:label "olopatadine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#omega-3
:omega-3 rdf:type owl:NamedIndividual ;
         rdfs:label "omega-3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#onchocerciasis
:onchocerciasis rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B73" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10030314 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Onchocerciasis" ;
                rdfs:label "onchocerciasis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#oralDiscomfort
:oralDiscomfort rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "K08. 9" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10030973 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Oral discomfort	" ;
                rdfs:label "oral discomfort" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#oropharyngealPain
:oropharyngealPain rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R07.0" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10068319 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Oropharyngeal pain" ;
                   rdfs:label "oropharyngeal pain" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#oxatomide
:oxatomide rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R06AE06" ;
           rdfs:label "oxatomide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#painInExtremity
:painInExtremity rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M79.606" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033425 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pain in extremity" ;
                 rdfs:label "pain in extremity" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#painInJaw
:painInJaw rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R68. 84" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033433 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pain in jaw" ;
           rdfs:label "pain in jaw" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#palpitations
:palpitations rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R00.2" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033557 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Palpitations" ;
              rdfs:label "palpitations" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#paraesthesia
:paraesthesia rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R20.2" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033775 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Paraesthesia" ;
              rdfs:label "paraesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#peripheralColdness
:peripheralColdness rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R20. 9" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10034568 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Peripheral coldness" ;
                    rdfs:label "peripheral coldness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#pioglitazone
:pioglitazone rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A10BG03" ;
              rdfs:label "pioglitazone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#potassiumCitrate
:potassiumCitrate rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A12BA02" ;
                  rdfs:label "potassium citrate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#potassiumcitrate
:potassiumcitrate rdf:type owl:NamedIndividual ;
                  rdfs:label "potassiumcitrate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#prasterone
:prasterone rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A14AA07" ;
            rdfs:label "prasterone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#predinose
:predinose rdf:type owl:NamedIndividual ;
           rdfs:label "predinose" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#pregabalin
:pregabalin rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX16" ;
            rdfs:label "pregabalin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#probiotics
:probiotics rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "QA07FA90" ;
            rdfs:label "probiotics" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#progesterone
:progesterone rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "G03DA04" ;
              rdfs:label "progesterone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#promethazine
:promethazine rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R06AD02" ;
              rdfs:label "promethazine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#propranolol
:propranolol rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C07AA05" ;
             rdfs:label "propranolol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#pruritus
:pruritus rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L29" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037087 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pruritus" ;
          rdfs:label "pruritus" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Signal> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> :Discussion_and_Conclusion ,
                                                                                      :Reports_in_VigiBase ,
                                                                                      :introduction ,
                                                                                      :summary ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_individual_case_report> :Report1 ,
                                                                                                 :Report10 ,
                                                                                                 :Report11 ,
                                                                                                 :Report12 ,
                                                                                                 :Report13 ,
                                                                                                 :Report14 ,
                                                                                                 :Report15 ,
                                                                                                 :Report16 ,
                                                                                                 :Report17 ,
                                                                                                 :Report18 ,
                                                                                                 :Report19 ,
                                                                                                 :Report2 ,
                                                                                                 :Report20 ,
                                                                                                 :Report21 ,
                                                                                                 :Report22 ,
                                                                                                 :Report23 ,
                                                                                                 :Report24 ,
                                                                                                 :Report25 ,
                                                                                                 :Report26 ,
                                                                                                 :Report27 ,
                                                                                                 :Report28 ,
                                                                                                 :Report29 ,
                                                                                                 :Report3 ,
                                                                                                 :Report4 ,
                                                                                                 :Report5 ,
                                                                                                 :Report6 ,
                                                                                                 :Report7 ,
                                                                                                 :Report8 ,
                                                                                                 :Report9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ,
                                                                                             :ReportsFromAfrica ,
                                                                                             :ReportsFromAmericas ,
                                                                                             :ReportsFromEurope ,
                                                                                             :ReportsWithFatalOutcome ,
                                                                                             :ReportsWithPositiveDechallenge ,
                                                                                             :Reports_for_ivermectin ,
                                                                                             :Reports_for_ivermectin_and_dizziness ,
                                                                                             :Reports_for_ivermectin_and_headache ,
                                                                                             :Reports_for_ivermectin_and_neurological_disorders ,
                                                                                             :Reports_for_ivermectin_and_pruritus ,
                                                                                             :Reports_from_case_series ,
                                                                                             :Reports_with_acarodermatitis_as_indication ,
                                                                                             :Reports_with_filariasis_as_indication ,
                                                                                             :Reports_with_myiasis_as_indication ,
                                                                                             :Reports_with_positive_rechallenge ,
                                                                                             :Reports_with_scabies_as_indication ,
                                                                                             :Reports_with_strongyloidiasis_as_indication ,
                                                                                             :Reports_with_taeniasis_as_indication ,
                                                                                             :Reprots_with_O._volvulus_as_indication ,
                                                                                             :Reprots_with_parasitic_infection_as_indication ,
                                                                                             :RreportsFromAsia ,
                                                                                             :reports_with_one_day_or_less_time_to_onset ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :Neurological_disorders ,
                                                                                   :neurological_complication ,
                                                                                   :neurological_event ,
                                                                                   :neurotoxicity ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ivermectin ;
          mp:supportedByData :Clinical_trial_information_for_ivermectin ,
                             :Product_labelling_for_ivermectin ,
                             :Public_health_programs_in_Africa ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#initially_identified_on> "1/1/2018" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#pyrexia
:pyrexia rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R50.9" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037660 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pyrexia" ;
         rdfs:label "pyrexia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#qualityOfLifeDecreased
:qualityOfLifeDecreased rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10067620 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Quality of life decreased" ;
                        rdfs:label "quality of life decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ranitidine
:ranitidine rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BA02" ;
            rdfs:label "ranitidine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#rebamipide
:rebamipide rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BX14 " ;
            rdfs:label "rebamipide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#redBloodCellCountDecreased
:redBloodCellCountDecreased rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R71.8" ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10038153 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Red blood cell count decreased" ;
                            rdfs:label "red blood cell count decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#reports_with_one_day_or_less_time_to_onset
:reports_with_one_day_or_less_time_to_onset rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallSeriousReportsInVigibaseForIvermectinForNeurologicalDisorders ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :One_day_or_less_time_to_onset ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 14 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                            rdfs:label "reports with one day or less time to onset" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#rigors
:rigors rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " R68.83" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008531 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chills" ;
        rdfs:label "rigors" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#risperidone
:risperidone rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05AX08" ;
             rdfs:label "risperidone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#ritonavir
:ritonavir rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J05AE03" ;
           rdfs:label "ritonavir" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#rivastigmine
:rivastigmine rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06DA03" ;
              rdfs:label "rivastigmine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#scabies
:scabies rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B86" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10063409 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Acarodermatitis" ;
         rdfs:label "scabies" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#scabiesInfestation
:scabiesInfestation rdf:type owl:NamedIndividual ;
                    rdfs:label "scabiesInfestation" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sedation
:sedation rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039897 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Sedation" ;
          rdfs:label "sedation" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#seizure
:seizure rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G40.9" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10039906 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Seizure" ;
         rdfs:label "seizure" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#senna
:senna rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A06AB06" ;
       rdfs:label "senna" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sensationOfHeaviness
:sensationOfHeaviness rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013082 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Discomfort" ;
                      rdfs:label "sensation of heaviness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C10AA01" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#skinEruption
:skinEruption rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R21" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037844 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Rash" ;
              rdfs:label "skin eruption" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sleepDisorder
:sleepDisorder rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "G47.9" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10040984 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Sleep disorder" ;
               rdfs:label "sleep disorder" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#somaticDelusion
:somaticDelusion rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "F22" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10041317 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Somatic delusion" ;
                 rdfs:label "somatic delusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#somnolence
:somnolence rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R40" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10041349 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Somnolence" ;
            rdfs:label "somnolence" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#statins
:statins rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Suggested_AE_Mechanism_regarding_CYP3A4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C10AA" ;
         rdfs:label "statins" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#summary
:summary rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Summary> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ivermectin is an anti-parasitic agent. It is indicated for use in the treatment of strongyloidiasis (Strongyloides stercoralis) and onchocerciasis (Onchocerca volvulus), but is also commonly used to treat scabies. Ivermectin is thought not to cross the blood-brain barrier in humans as it is excluded by a P-glycoprotein drug pump (mdr-1). Therefore, it has been considered to be free of the potential to cause neurological adverse drug reactions, except in situations of overdose. Serious neurological adverse events (SNAEs) were initially reported in public health programs in Africa to eliminate onchocerciasis through community-based ivermectin treatment. Cases of encephalopathy and coma were reported in Cameroon and the Democratic Republic of Congo in persons who concomitantly harbored high densities of another filarial species, Loa loa. Subsequent analyses revealed a correlation between pre-ivermectin treatment Loa microfilarial density and the risk of developing an SNAE. In VigiBase, the WHO global database of individual case safety reports, a report describing a case of encephalopathy with ivermectin from the Democratic Republic of Congo, which reported a lack of evidence of concomitant loaiasis, triggered a review of the database. This led to the identification of a case series of SNAEs occurring with the use of ivermectin outside the onchocerciasis indication. The occurrence of an SNAE after ivermectin may therefore not be entirely explained by concomitant onchocerciasis or loiasis infections. Knowledge of potential drug interactions and exploration of  individual variations in the mdr-1 gene may be warranted to ensure safer use of ivermectin." ;
         rdfs:label "summary" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#swollenTongue
:swollenTongue rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R22.0" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10042727 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Swollen tongue" ;
               rdfs:label "swollen tongue" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#tachycardia
:tachycardia rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R00.0" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043071 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Tachycardia" ;
             rdfs:label "tachycardia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#terbinafine
:terbinafine rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "D01AE15" ;
             rdfs:label "terbinafine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#thinkingAbnormal
:thinkingAbnormal rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R41.89" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043431 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Thinking abnormal" ;
                  rdfs:label "thinking abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#toprimate
:toprimate rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AX11 " ;
           rdfs:label "toprimate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#trazadone
:trazadone rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AX05 " ;
           rdfs:label "trazadone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#tremor
:tremor rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R25.1" ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10044565 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Tremor" ;
        rdfs:label "tremor" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#troxipide
:troxipide rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BX11" ;
           rdfs:label "troxipide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#unableToWalk
:unableToWalk rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R26. 2" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10017581 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gait inability" ;
              rdfs:label "unable to walk" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#unconsciousness
:unconsciousness rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R40.20" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10024855 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Loss of consciousness" ;
                 rdfs:label "unconsciousness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#urineColourAbnormal
:urineColourAbnormal rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R82.99" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10008796 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chromaturia" ;
                     rdfs:label "urine colour abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#usage_of_ivermectin
:usage_of_ivermectin rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Strongyloidiasis ,
                                                                                                 :onchocerciasis ,
                                                                                                 :scabies ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ivermectin ;
                     rdfs:label "usage of ivermectin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#valproicAcid
:valproicAcid rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AG01" ;
              rdfs:label "valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#vertigo
:vertigo rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R42" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047340 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Vertigo" ;
         rdfs:label "vertigo" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#visionDecreased
:visionDecreased rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "H54" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047571 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Visual impairment" ;
                 rdfs:label "vision decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#vitaminD
:vitaminD rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A11CC" ;
          rdfs:label "vitamin d" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#vitamins
:vitamins rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A11" ;
          rdfs:label "vitamins" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#vomiting
:vomiting rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R11" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047700 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#weightDecreased
:weightDecreased rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R63.4" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047895 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Weight decreased" ;
                 rdfs:label "weight decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#whiteBloodCellCountDecreased
:whiteBloodCellCountDecreased rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "D72.819" ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047942 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "White blood cell count decreased" ;
                              rdfs:label "white blood cell count decreased" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Piperonyl_butoxide/_esdepallethrime
<http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#Piperonyl_butoxide/_esdepallethrime> rdf:type owl:NamedIndividual ,
                                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "P03AX" ;
                                                                                                                           rdfs:label "Piperonyl butoxide/ esdepallethrime" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#formoterol/budesonide
<http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#formoterol/budesonide> rdf:type owl:NamedIndividual ,
                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R03AK07" ;
                                                                                                             rdfs:label "formoterol/budesonide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sennosidea+b
<http://purl.org/OpenPVSignal/Signals/2018_1_ivermectin_seriousNeurologicalEvents.owl#sennosidea+b> rdf:type owl:NamedIndividual ;
                                                                                                    rdfs:label "sennosidea+b" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
